Biotech Trade Group BIO Sues Over Medicare GLOBE Pricing Pilot

BIO and two California biotech trade groups have filed a lawsuit in federal court to stop the Medicare GLOBE pilot that would tie US drug prices to those in peer nations.

The complaint argues the Global Benchmark for Efficient Drug Pricing demonstration exceeds Medicare's statutory authority, seeking an injunction to halt the model.

The Centers for Medicare and Medicaid Services has not responded to comment requests, and the industry views the pilot as a limited impact but a precedent-setting effort they want to prevent.